Easton Pharmaceuticals Inc. Share Price Other OTC
Equities
EAPH
US2777741057
Biotechnology & Medical Research
Sales 2019 | 1.56M 122M | Sales 2020 | - | Capitalization | 807K 63.44M |
---|---|---|---|---|---|
Net income 2019 | - 0 | Net income 2020 | - 0 | EV / Sales 2019 | 6.27 x |
Net Debt 2019 | 8.41M 661M | Net Debt 2020 | 2.48M 195M | EV / Sales 2020 | - |
P/E ratio 2019 |
-4.17
x | P/E ratio 2020 |
-4.29
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 29/06/15 |
Vince Demasi
COO | Chief Operating Officer | - | 19/06/18 |
Chief Tech/Sci/R&D Officer | - | 31/12/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 29/06/15 |
John Guerra
SEC | Corporate Secretary | - | 30/12/13 |
Vince Demasi
COO | Chief Operating Officer | - | 19/06/18 |
1st Jan change | Capi. | |
---|---|---|
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |